FRISCO, Texas, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource (MDO) manufacturer, today announced that Michael Dinkins, executive vice president and chief financial officer, plans to leave the Company. The Company has commenced a search for his successor, and Mr. Dinkins will continue to serve as executive vice president and chief financial officer for up to six months or such earlier date when his successor is named.

The danger of falling for a senior is a real threat, especially for those who are alone for extended periods of time. Blue Willow Systems is changing the way older individuals are monitored with wearable technology that improves patient monitoring.

Allergan and Medicines360 have teamed up to launch the LILETTA, a 52 mg IUD single-handed inserter.

Inhibikase Therapeutics has received FDA approval to begin two proof-of-principle trials to use its kinase inhibitor strategy as a possible treatment for Parkinson's disease.

The nation’s largest for-profit health system is taking extra measures to make sure its patients don’t contract MRSA, which the CDC says killed more than 9,000 patients who contracted the infection in healthcare settings in 2014 alone. 

A modest rise in premiums, a big increase in deductibles and a move away from paid provider organization (PPO) plans are among the notable results in the annual survey on employer-sponsored health benefits from the Kaiser Family Foundation and the Health Research and Educational Trust (HRET).

While contaminated water systems have received more attention thanks to the lead-tainted drinking water in Flint, Michigan, the healthcare costs of infections caused by waterborne bacteria have been increasing for years, according to a study published in the Journal of Public Health.

Ablative Solutions has received approval from the FDA for the continuation of testing on its Peregrine System Kit for catheter-based renal denervation with precision delivery of alcohol treatment for hypertension.